Denali Advisors’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-22,000
Closed -$169K 321
2024
Q1
$169K Hold
22,000
0.05% 241
2023
Q4
$93.7K Sell
22,000
-4,700
-18% -$20K 0.03% 273
2023
Q3
$112K Hold
26,700
0.04% 264
2023
Q2
$149K Buy
+26,700
New +$149K 0.05% 240